Dong, W.; Imdad, L.; Xu, S.; Wang, Y.; Liu, C.; Song, S.; Li, Z.; Kong, Y.; Kong, L.; Ren, X.
O-GlcNAc Modification Is a Promising Therapeutic Target for Diabetic Retinopathy. Int. J. Mol. Sci. 2024, 25, 6286.
https://doi.org/10.3390/ijms25116286
AMA Style
Dong W, Imdad L, Xu S, Wang Y, Liu C, Song S, Li Z, Kong Y, Kong L, Ren X.
O-GlcNAc Modification Is a Promising Therapeutic Target for Diabetic Retinopathy. International Journal of Molecular Sciences. 2024; 25(11):6286.
https://doi.org/10.3390/ijms25116286
Chicago/Turabian Style
Dong, Wenkang, Laraib Imdad, Shengnan Xu, Yinli Wang, Chengzhi Liu, Shiyu Song, Zechuan Li, Ying Kong, Li Kong, and Xiang Ren.
2024. "O-GlcNAc Modification Is a Promising Therapeutic Target for Diabetic Retinopathy" International Journal of Molecular Sciences 25, no. 11: 6286.
https://doi.org/10.3390/ijms25116286
APA Style
Dong, W., Imdad, L., Xu, S., Wang, Y., Liu, C., Song, S., Li, Z., Kong, Y., Kong, L., & Ren, X.
(2024). O-GlcNAc Modification Is a Promising Therapeutic Target for Diabetic Retinopathy. International Journal of Molecular Sciences, 25(11), 6286.
https://doi.org/10.3390/ijms25116286